Paracetamol is connected to ADHD in children during pregnancy
A new study found pregnant women who used acetaminophen, or paracetamol, later gave birth to children, the possibility of receiving ADHD diagnosis more than three times.
There are some painkillers that are safe to use during pregnancy and one of them has created a storm of international debate.
Acetaminophen, also known as paracetamol, is generally considered the safest pain reliever to use during pregnancy.
However, new research connecting the drug to the hyperclass disorder (ADHD) of the deficit shows that risks may be ignored for brain development.
In a small new study, researchers at the University of Washington traveled the level of bloodstream of acetaminophen in 307 black women during their pregnancy.
A study published in Peer-Ruined Nature Mental Health found that those who use acetaminophen, later gave birth to children, more than three times the possibility of receiving ADHD diagnosis.
For daughters, in the first ten years of life, ADHD’s risk was associated with more than six times the increase in exposure to acetaminophen in the womb.
ADHD, or meditation-throat/hypercarctivity disorder, is a brain-based disorder that affects children’s behavior. According to the Cleveland Clinic, it is quite common in children, where they have difficulty with inadvertence, overdose, and impulse.
While it seems to be related to the surface, these initial results are not decisive and should not scare a large percentage of those who rely on acetaminophen during pregnancy for pain or fever.
Strong evidence suggests that both those symptoms may be a threat to a developing fetus, if left untreated. With any drug, the benefits of acetaminophen should be balanced by risks. Unlike its professionals, however, long -term opposition has not been researched as well.
Sheela Satinarayan, a pediatrician at UW Medicine, told science alert, “This drug was approved decades ago, and may require re -evaluation by the FDA. Acetaminophen could never be evaluated to expose the fetus in relation to long -term neurodeological effects”.
Due to the size of the small sample of the current study, the data is probably US Food and Drug Administration (FDA), European Medicine Agency (EMA), American College of Obstaterisian and Gynecologist (ACOG), The Society of Obstaterisian and Gynecologist of Obstators and Gynecologist of DIDISIN The brain is not sufficiently strong to change. during pregnancy.
Despite the limitations of the study, the findings suggest that it may be time for FDA to re -evaluate the safety of acetaminophen during pregnancy.
In 2015, FDA officials announced that there were indicative evidence to connect the use of acetaminophen during pregnancy and to add ADHD to children.
Further studies will be necessary to establish a clear understanding of the possible risks involved.
